Magnetic resonance spectroscopy of brain tumours;1H-Magnetresonanz-spektroskopie von hirntumoren

Nervenarzt

Volumn 76, Issue 4, 2005, Pages 403-417

  Harting, I ^a   Jost, G ^a   Hacke, N ^a   Hartmann, M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Brain neoplasms; Glioma; Lymphoma; MR spectroscopy

Indexed keywords

ALANINE; CHOLINE DERIVATIVE; CONTRAST MEDIUM; CREATINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LIPID; N ACETYLASPARTIC ACID; SUCCINIC ACID; VALINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DIAGNOSTIC AGENT; PROTON; TUMOR MARKER;

ABSCESS; BRAIN TUMOR; CORRELATION ANALYSIS; CYST; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GLIOMA; HUMAN; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; METABOLISM; METASTASIS; NEUROECTODERM TUMOR; NEUROEPITHELIOMA; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TISSUE NECROSIS; TUMOR GROWTH; TURNOVER TIME; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TISSUE DISTRIBUTION;

BRAIN NEOPLASMS; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; NEUROTRANSMITTER AGENTS; PROTONS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 23944499181     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1797-1     Document Type: Review

References (47)

1. Barbarella G, Ricci R, Pirini G et al. (1998) In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS. Int J Oncol 12:461-468
2. Bhakoo KK, Pearce D (2000) In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74:254-262
3. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298
4. Bulakbashi N, Kocaoglu M, Örs F et al. (2003) Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Am J Neuroradiol 23:225-233
5. Burtscher IM, Holtas S (1999) In vivo proton MR spectroscopy of untreated and treated brain abscesses. Am J Neuroradiol 20:1049-1053
6. Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am 8:733-752
7. Danielsen ER, Michaelis T, Ross BD (1995) Three methods of calibration in quantitative proton MR spectroscopy. J Magn Reson B 106:117-191
8. Davie CA, Hawkins CP, Barker GJ et al. (1994). Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117:49-58
9. Duijn JH, Matson GB, Maudsley AA et al. (1992) Human brain infarction: proton MR spectroscopy. Radiology 183:711-718
10. Earnest FI, Kelly PJ, Scheithauer BW et al. (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823-827
11. Ebisu T, Tanaka C, Umeda M et al. (1996) Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. J Magn Reson Imag 14:1113-1116
12. Florian CL, Preece NA, Bhakoo KK et al. (1995) Cell type-specific fingerprinting of meningioma and menigeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res 55:420-427
13. Fulham MJ, Bizzi A, Dietz MJ et al. (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675-686
14. Grand S, Passaro G, Ziegler A et al. (1999) Necrotic tumor versus brain abscess: Importance of amino acids detected at 1H MR spectroscopy - initial results. Radiology 213:785-793
15. Grodd W, Krägeloh-Mann I, Petersen D et al. (1990) In vivo assessment of N-acetyl-aspartate in brain in spongy degeneration (Canavan's disease). Lancet 2:437-438
16. Guo AC, Cummings TJ, Dash RC et al. (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177-183
17. Harling I, Hartmann M, Bonsanto MM et al. (2004) Characterization of necrotic meningioma using diffusion MRI, perfusion MRI, and MR spectroscopy: case report and review of the literature. Neuroradiology 46:189-193
18. Harting I, Hartmann M, Jost G et al. (2003) Differentiating primary central nervous system lymphoma from glioma using MR spectroscopy. Neurosci Lett 342:163-166
19. Hartmann M, Heiland S, Harting I et al. (2003) Distinguishing of primary intracerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119-122
20. Hartmann M, Jansen O, Heiland S et al. (2001) Restricted diffusion with ring enhancement is not pathognomonic for brain abscesses. Am J Neuroradiol 22:1738-1742
21. Im SH, Chung CK, Cho BK et al. (2002) Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol 59:173-183
22. Jayasundar R, Shah T, Vaishya S et al. (2003) In vivo and in vitro MR spectroscopic profile of central neurocytomas. J Magn Reson Imaging 17:256-260
23. Kleihues P, Cavenee WK (2000) Pathology and genetics of tumors of the nervous system. IARC
24. Kuesel AC, Donnelly SM, Halliday W et al. (1993) Mobile lipids and metabolic heterogeneity of brain tumours as detectable by ex vivo 1H MR spectroscopy. NMR Biomed 7:172-180
25. Kugel H, Heindel W, Ernestus R-I et al. (1992) Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183:701-709
26. Kumabe T, Shimizu H, Sonoda Y et al. (1999) Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports. Neurosurgery 45:183-187
27. Majos C, Alonso J, Aguilera C et al. (2002) Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Radiology 225:556-566
28. Martin E, Capone A, Schneider J et al. (2001) Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 49:518-521
29. Meyerand ME, Pipas JM, Mamourian A et al. (1999) Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. Am J Neuroradiol 20:117-123
30. Michaelis T, Merboldt KD, Hänicke W et al. (1991) On the identification of cerebral metabolites in localized 1H NMR spectra of human brain in vivo. NMR Biomed 4:90-98
31. Miller BL (1991) A review of the chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine, and choline. NMR Biomed 4:47-52
32. Miller BL, Chang L, Booth R et al. (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929-1935
33. Negendank WG, Sauter R, Brown TR et al. (1996) Proton magnetic resonance in patients with glial tumors: a multicenter study. J Neurosurg 84:449-458
34. Nelson SJ, Vigneron DB, Dillon WP (1999) Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 12:123-138
35. Ott D, Henning J, Ernst T (1993) Human brain tumors: assessment with in vivo MR spectroscopy. Radiology 186:745-752
36. Poptani H, Gupa RK, Jain VK et al. (1995) Cystic intracranial mass lesions: Possible role of in vivo MR spectroscopy in its differential diagnosis. J Magn Reson Imag 13:1019-1029
37. Preul CM, Caramanos Z, Leblanc R et al. (1998) Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 11:192-200
38. Ross BD (1991) Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 4:59-63
39. Saunders DE, Howe FA, van den Boogaart A et al. (1995) Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 26:1007-1013
40. Schlemmer HP, Bachert P, Herfarth KH et al. (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. Am J Neuroradiol 22:1316-1324
41. Schulze A (2003) Creatine deficiency syndromes. Mol Cell Biochem 44:143-150
42. Shino A, Nakasu S, Matsuda M et al. (1999) Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91:928-934
43. Sijens PE, van den Bent M, Nowak PJCM et al. (1997) 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 37:222-225
44. Tedeschi G, Lundbom N, Raman R et al. (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524
45. Tien RD, Lai Ph, Smith JS et al. (1996) Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. Am J Roentgenol 167:201-209
46. van der Knaap MS, Wevers RA, Struys EA et al. (1999) Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 46:925-928
47. Wang Z, Sutton LN, Cnaan A et al. (1995) Proton MR spectroscopy of pediatric cerebellar tumors. Am J Neuroradiol 16:1821-1833